U W Preuss1, P Zill, G Koller, B Bondy, M Sokya. 1. Pediatric Hospital of Ludwig-Maximilians-University, Munich, Germany. ulrich.preuss@medizin.uni-halle.de
Abstract
INTRODUCTION: Alcohol dependence and habitual smoking frequently co-occur and possibly mutually influence each other. Both have been related to alterations of dopaminergic neurotransmission. The aim of this analysis of the Munich Gene Data Bank for Alcoholism(MGBA) was to re-evaluate the potential relation between D2 receptor and dopamine transporter gene haplotypes and quantity-related phenotypes of alcohol consumption (average daily alcohol intake before admission for treatment) and smoking (average units smoked per day). METHODS: A total of 333 inpatients (265 males) were enrolled in the study, all of who met the ICD10 diagnosis of alcohol dependence. Mild and strong quantity drinkers and smokers were separated into groups by median split. A number of genetic markers were chosen across D2 dopamine receptor gene (-141 Ins/Del, Taq1B, Taq1D, Ser311Cys; rs1079594 (intron 7); Taq1A) and dopamine transporter (40bp variable number of tandem repeat; rs2617605 (intron 2); rs37022 (intron 7); rs40184 (intron 14)). Genotyping was performed using PCR. RESULTS: Strong drinkers reported significantly higher amounts of smoking and vice versa. While no association was detected for dopamine transporter genetic variants, a number of D2 receptor gene single nucleotide polymorphisms were related to both smoking- and drinking-related behaviours. Subsequent analysis of D2 receptor gene haplotypes revealed that two common haplotypes had a significant association with quantitative phenotypes of regular drinking (Ins-C-G-C-A1) and smoking (Ins-T-G-A-A2). DISCUSSION: The finding of an association between common D2 dopamine receptor gene haplotypes with the quantity of drinking and smoking corroborates with results from previous studies suggesting a relationship between the dopamine system and alcohol and substance use disorders. Furthermore, it makes D2 dopamine receptor a candidate gene significantly influencing both alcohol and nicotine dependence.
INTRODUCTION:Alcohol dependence and habitual smoking frequently co-occur and possibly mutually influence each other. Both have been related to alterations of dopaminergic neurotransmission. The aim of this analysis of the Munich Gene Data Bank for Alcoholism(MGBA) was to re-evaluate the potential relation between D2 receptor and dopamine transporter gene haplotypes and quantity-related phenotypes of alcohol consumption (average daily alcohol intake before admission for treatment) and smoking (average units smoked per day). METHODS: A total of 333 inpatients (265 males) were enrolled in the study, all of who met the ICD10 diagnosis of alcohol dependence. Mild and strong quantity drinkers and smokers were separated into groups by median split. A number of genetic markers were chosen across D2 dopamine receptor gene (-141 Ins/Del, Taq1B, Taq1D, Ser311Cys; rs1079594 (intron 7); Taq1A) and dopamine transporter (40bp variable number of tandem repeat; rs2617605 (intron 2); rs37022 (intron 7); rs40184 (intron 14)). Genotyping was performed using PCR. RESULTS: Strong drinkers reported significantly higher amounts of smoking and vice versa. While no association was detected for dopamine transporter genetic variants, a number of D2 receptor gene single nucleotide polymorphisms were related to both smoking- and drinking-related behaviours. Subsequent analysis of D2 receptor gene haplotypes revealed that two common haplotypes had a significant association with quantitative phenotypes of regular drinking (Ins-C-G-C-A1) and smoking (Ins-T-G-A-A2). DISCUSSION: The finding of an association between common D2 dopamine receptor gene haplotypes with the quantity of drinking and smoking corroborates with results from previous studies suggesting a relationship between the dopamine system and alcohol and substance use disorders. Furthermore, it makes D2 dopamine receptor a candidate gene significantly influencing both alcohol and nicotine dependence.
Authors: Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor Journal: Nicotine Tob Res Date: 2009-01-27 Impact factor: 4.244
Authors: Sarah A Thomas; Justin W Weeks; Lea R Dougherty; Melanie F Lipton; Samantha E Daruwala; Kathryn Kline; Andres De Los Reyes Journal: J Psychopathol Behav Assess Date: 2015-05-19
Authors: Robert A Moyer; Danxin Wang; Audrey C Papp; Ryan M Smith; Linda Duque; Deborah C Mash; Wolfgang Sadee Journal: Neuropsychopharmacology Date: 2010-12-08 Impact factor: 7.853
Authors: Julia K Pinsonneault; Dawn D Han; Katherine E Burdick; Maria Kataki; Alessandro Bertolino; Anil K Malhotra; Howard H Gu; Wolfgang Sadee Journal: Neuropsychopharmacology Date: 2011-04-27 Impact factor: 7.853
Authors: Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold Journal: Postgrad Med Date: 2009-11 Impact factor: 3.840
Authors: Ali M Yurasek; James G Murphy; Ashley Hum Clawson; Ashley A Dennhardt; James MacKillop Journal: J Stud Alcohol Drugs Date: 2013-07 Impact factor: 2.582
Authors: Kenneth Blum; Amanda L C Chen; Marlene Oscar-Berman; Thomas J H Chen; Joel Lubar; Nancy White; Judith Lubar; Abdalla Bowirrat; Eric Braverman; John Schoolfield; Roger L Waite; Bernard W Downs; Margaret Madigan; David E Comings; Caroline Davis; Mallory M Kerner; Jennifer Knopf; Tomas Palomo; John J Giordano; Siobhan A Morse; Frank Fornari; Debmalya Barh; John Femino; John A Bailey Journal: Int J Environ Res Public Health Date: 2011-11-29 Impact factor: 3.390